GPC Biotech
GPC Biotech was a German biopharmaceutical company focused on the development of cancer therapeutics, notably including the drug candidate satraplatin. The company was acquired by Apeiron Biologics in 2009 and subsequently ceased independent operations.
Brand Identity Data
HQ Country
Germany
HQ City
Martinsried
Founded
1997
EU Headquartered
Yes
EU Manufactured
No
Stock Exchange
Private
Repair / Recycling
No
Ethical Certifications
None verified
Verified on July 22, 2026